Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001946798 | SCV002240145 | pathogenic | LAMA2-related muscular dystrophy | 2020-12-02 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp1563*) in the LAMA2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LAMA2 are known to be pathogenic (PMID: 18700894). This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with LAMA2-related conditions. For these reasons, this variant has been classified as Pathogenic. |
Genomic Medicine Center of Excellence, |
RCV003984866 | SCV004801221 | pathogenic | Merosin deficient congenital muscular dystrophy | 2024-03-14 | criteria provided, single submitter | research |